Tag: immune checkpoint inhibitors

IASLC faculty members from Europe, Asia and North America will discuss systemic therapies including chemotherapy, immunotherapy, and targeted therapy for advanced-stage lung cancer during...

By Enza Esposito Nguyen, DNP, RN, ANP-BC Posted: February 12, 2020 Although we continue to see many immunotherapy clinical trials mature and deliver marvelous improvements in...

This article is the second in a two-part series on ongoing challenges using immunotherapy in special populations. The first part of this series focused on...

By Suresh Ramalingam, MD Posted: December 11, 2019 IN REFERENCE TO: Garon EB, Hellmann MD, Rizvi NA, et al. Five-Year Overall Survival for Patients With Advanced...